In the normoprolactinemic population in general, higher PRL levels within the normal range were associated with improved insulin sensitivity and glucose metabolism, and lower prevalence of diabetes and metabolic syndrome (85–88). The gene discussed is PRL; the disease is metabolic syndrome.